Critical DMPK and toxicology insights for oncology teams

Oncology drug development is among the most complex and costly endeavours in modern biomedical research. Despite promising mechanisms of action and preclinical efficacy, many candidates fail due to insufficient absorption, metabolism issues, or toxicological issues.

Explore this guide as it outlines the fundamentals of DMPK (drug metabolism and pharmacokinetics) and predictive toxicology, and learn of the strategies available that can help you make informed decisions earlier, to de-risk the pipeline and accelerate the path to investigational new drug (IND) submission.